Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PhageLab

Explore full profile

Phage Lab is a laboratory dedicated to animal welfare, with solutions for the efficient control of bacteria in the poultry, cattle and aquaculture production systems industry

Macul, ChileFounded 2010Food
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PhageLab and the history behind them.

About PhageLab

PhageLab is a biotechnology company specializing in the development of sustainable, antibiotic-free solutions to control bacterial outbreaks in the livestock and poultry industries. Operating primarily in Latin America, PhageLab serves poultry and livestock producers by providing tailored bacteriophage cocktails that target specific bacterial pathogens. The company leverages its extensive collections of bacteria and phages, among the largest in the world, to create customized treatments that enhance animal health and food safety. PhageLab's business model involves a subscription-based service, allowing clients to receive regular updates and new formulations as needed. Revenue is generated through these subscriptions and the sale of diagnostic services, which include non-invasive protocols to detect and understand pathogenic bacteria without disrupting farm operations. By accelerating the development of these solutions, PhageLab contributes to a more sustainable and safer food production system.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2010
Headquarters
Macul, Chile
Employees
97
Open positions
None listed
Dealroom signal
57.0/100
Industry
Food
Sub-industry
AgriTech
Sector
Food, Biotechnology, Bacteria, Biotechnology in Food, Animal Farming
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLE✓Equity / VC Dec 2025 $3.5M — KaszeK Ventures ↗
GRANT✓Other financing Oct 2024 $110K — The Yield Lab ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

PhageLab website traffic

Latest recorded traffic for PhageLab is 1.5K monthly website visits, down 53.1% over the last three months. PhageLab's team declined 12.6% over the past year.

Latest monthly visits1.5K 3-month web change-53.1% 1-year team growth-12.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Native MicrobialsNovel microbial community screening methods to discover, develop, and commercialise next generation feed additives San Diego, United States Operational 40 $60M $184M
AviwellDevelop natural and sustainable solutions to improve animal health to better nourish and provide food security to the nearly 8 billion people on our planet. And to do so a fraction of the cost Toulouse, France Operational
Eclipse IngredientsInnovative plant-based ingredients enhancing taste and nutrition Brisbane, Australia Operational
NetaGenomiXCRISPR-based solutions for developing climate-resilient and nutritious crops Holon, Israel Operational
InnoplantFocusing on agricultural research Santa Fe, Spain Operational
Magicpen BioAn agricultural technology developer focused on cutting-edge research to improve crop quality, yield, stress resistance, and adaptability through gene editing and genetic improvement Hefei, China Operational
ActiveCross CorporationActiveCross harnesses engineered living organisms to produce innovative small molecules that protect crops, enabling safe and sustainable agriculture Atlanta, United States Operational
RNAwayBiodegradable RNA delivery platform enhancing crop yield and resilience while reducing reliance on harmful chemicals Herzliya, Israel Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Start-Up Chile
  • The Yield Lab

Series A1 investor entered at this stage

Series B and later4 investors entered at this stage

Other known investors4 additional known investors

  • Cristian Hernandez-Cuevas
  • Humboldt Fund
  • Technology Pioneers | World Economic Forum
  • The Yield Lab Latam
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇨🇱 Chile77.3%
🇧🇷 Brazil17.3%
🇬🇧 United Kingdom1.3%
🇺🇸 United States1.3%
🇪🇸 Spain1.3%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PhageLab on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PhageLab’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.